Clinical trial

Next Generation Rocklatan

NCT06441643

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-09-04

PhasePHASE2

Study timeline

Study start (actual)2024-09-04Date precision: day

Registry last updated2025-11-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Open Angle Glaucomaunresolved

Ocular Hypertensionunresolved

Interventions

AR-17043 Ophthalmic SolutionDRUG

PG043 Ophthalmic SolutionDRUG

Latanoprost 0.005% Ophthalmic SolutionDRUG

Netarsudil 0.02% Ophthalmic SolutionDRUG

Netarsudil 0.02%/Latanoprost 0.005% Ophthalmic SolutionDRUG

AR-17043 VehicleDRUG

Sponsors & collaborators

Alcon Researchlead sponsor

Mapped research locations

RochesterNew York, United States1 Winston-SalemNorth Carolina, United States1 MemphisTennessee, United States1 Newport BeachCalifornia, United States1 Garden GroveCalifornia, United States1 Fort CollinsColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06441643 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.